Endocrinology · Resistance to Thyroid Hormone

Standard of Care and Treatment Approaches

At a Glance

Treatment for thyroid hormone resistance is individualized: many people with RTH-beta need monitoring rather than medicine, while symptoms may be treated with beta-blockers or TRIAC. RTH-alpha may require carefully adjusted levothyroxine under specialist care.

Managing Resistance to Thyroid Hormone (RTH) is different from managing almost any other thyroid condition. In most thyroid disorders, the goal is to get your blood test numbers back into the “normal” range. In RTH, those high numbers may be exactly what your body has generated to function ^[1]^[2]. Management must be highly individualized.

RTH-Beta: Observation and Active Surveillance

For many people with RTH-Beta who are clinically compensated, observation (active surveillance) is a reasonable approach ^[3].

Because your tissues are “resistant,” your body naturally raises its hormone levels to overcome that resistance. If you feel well and your examination, growth, heart rhythm, and labs show no negative effects, your doctor may recommend periodic check-ups rather than medication ^[4]^[5].

Treating Symptoms in RTH-Beta

If RTH-Beta causes bothersome symptoms, treatment focuses on the specific problem rather than the hormone levels themselves:

Beta-Blockers: Medications like atenolol or propranolol are often used to treat tachycardia (fast heart rate) or palpitations ^[6]^[7]. These help the heart feel more comfortable but do not change your thyroid blood tests.
TRIAC (Tiratricol): This is a specialized, often off-label form of thyroid hormone. In selected cases directed by a specialist, TRIAC can help lower T4 and T3 levels while managing symptoms ^[8]^[9]. Availability varies by country.
- Note: TRIAC can interfere with standard lab tests, making it look like your levels are different than they actually are. Specialized testing is required while taking it ^[10].

Avoiding Treatment Solely for Lab Numbers

In RTH-Beta, standard treatments for an “overactive” thyroid are generally not appropriate if used solely to normalize the laboratory values ^[1]^[11].

If a doctor tries to “fix” your high levels with antithyroid drugs, radioactive iodine, or surgery (thyroidectomy), it can lead to complications such as severe tissue hypothyroidism, massive goiters, or pituitary enlargement ^[12]^[13]^[14].

Important Exception: These interventions can be appropriate if you have a coexisting condition that requires them, such as true Graves’ disease, thyroid nodules, or thyroid cancer. Any such treatment requires an endocrinologist who understands your RTH diagnosis.

RTH-Alpha: A Specialized Approach

Unlike the Beta type, symptomatic people with RTH-Alpha may require active treatment with Levothyroxine (L-T4) ^[15].

Because their tissues (like bones and the gut) are not getting enough “signal,” specialists may use individualized doses of thyroid hormone.

The Evidence: Evidence for treating RTH-Alpha comes largely from small case series. Early treatment in infants and children may help with growth and developmental milestones ^[15]^[16].
Symptom Relief: Treatment may help resolve chronic constipation and improve energy ^[16]^[17].
Limitations and Risks: Dose goals are not uniform. Excessive dosing can expose sensitive tissues (like the heart) to too much hormone, leading to tachycardia. Furthermore, developmental benefit cannot be guaranteed, and some established bone changes may not resolve ^[18]^[16].

In both types of RTH, your “best” management is determined by your symptoms, examination, growth, and appropriately interpreted laboratory results, directed by specialist supervision ^[1]^[19].

Common questions in this guide

Do high thyroid hormone levels always need treatment in RTH?

No. In RTH-beta, people who feel well and have reassuring examination findings, growth, heart rhythm, and laboratory results may be managed with regular monitoring instead of medication because higher levels can be the body’s way of compensating for reduced tissue sensitivity.

How are a fast heart rate and palpitations treated in RTH-beta?

An endocrinologist may recommend a beta-blocker such as atenolol or propranolol to slow the heart rate and reduce palpitations. These medicines can improve symptoms but generally do not change thyroid hormone results.

What is TRIAC, and why would I need special testing while taking it?

TRIAC, also called tiratricol, is a specialized thyroid hormone treatment that may be used in selected cases to help manage symptoms and lower T4 and T3 levels. It can interfere with standard thyroid blood tests, so a specialist may use specialized testing and careful clinical monitoring.

Could levothyroxine help someone with RTH-alpha?

Possibly. Specialists may use individualized levothyroxine doses for symptomatic RTH-alpha, particularly in infants or children, to support growth and development and improve problems such as constipation or low energy. The evidence is limited, and too much hormone can cause a fast heart rate, so dosing requires close supervision.

Should I take antithyroid medicine or have radioactive iodine for RTH?

Usually not if the only goal is to make thyroid blood tests look normal in RTH-beta. These treatments, and thyroid surgery, can leave tissues with too little thyroid hormone and cause serious complications; they may still be appropriate when a separate condition such as Graves’ disease, thyroid nodules, or thyroid cancer requires them.

How will my doctor decide whether to monitor or treat RTH?

Treatment is based on the RTH type, symptoms, physical examination, growth, heart rhythm, and laboratory results interpreted in context rather than on a single high hormone value. An endocrinologist should guide the plan, especially when a child is affected or another thyroid condition is present.

Get notified when new evidence is published on thyroid hormone resistance syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Key takeaways

Many people with clinically compensated RTH-beta can be monitored without medication because higher thyroid hormone levels may be the body’s compensation for tissue resistance.
Beta-blockers such as atenolol or propranolol can ease tachycardia and palpitations without changing thyroid blood test results.
TRIAC (tiratricol) may be considered for selected RTH-beta patients, but it can interfere with standard thyroid testing and requires specialist monitoring.
RTH-alpha may be treated with individualized levothyroxine, especially in children, although developmental benefits are not guaranteed and too much hormone can cause tachycardia.
Antithyroid drugs, radioactive iodine, or thyroidectomy should not be used simply to normalize laboratory values in RTH-beta unless a separate thyroid condition makes them necessary.

References (19)

1
Graves' Masquerade: A Case of Resistance to Thyroid Hormone (RTH) Syndrome.
Chin YH, Anthony Bernard DM, Foo SH
Cureus 2025; (17(1)):e78160 doi:10.7759/cureus.78160.
PMID: 40027009
2
Human Genetics of Thyroid Hormone Receptor Beta: Resistance to Thyroid Hormone Beta (RTHβ).
Pappa T, Refetoff S
Methods in molecular biology (Clifton, N.J.) 2018; (1801()):225-240 doi:10.1007/978-1-4939-7902-8_18.
PMID: 29892828
3
Resistance to Thyroid Hormone Beta: A Focused Review.
Pappa T, Refetoff S
Frontiers in endocrinology 2021; (12()):656551 doi:10.3389/fendo.2021.656551.
PMID: 33868182
4
Cardiovascular Risk and Plasma N-terminal Pro-B-type Natriuretic Peptide in Adults With Resistance to Thyroid Hormone β.
Davis TME, Davis WA, Moran C, et al.
Journal of the Endocrine Society 2025; (9(4)):bvaf023 doi:10.1210/jendso/bvaf023.
PMID: 40065989
5
Dyslipidemia, Insulin Resistance, Ectopic Lipid Accumulation, and Vascular Function in Resistance to Thyroid Hormone β.
Moran C, McEniery CM, Schoenmakers N, et al.
The Journal of clinical endocrinology and metabolism 2021; (106(5)):e2005-e2014 doi:10.1210/clinem/dgab002.
PMID: 33524107
6
A Novel THRβ Variant in a Child With Resistance to Thyroid Hormone β: Diagnostic and Therapeutic Challenges.
Gürpınar G, Aracı DG
Journal of clinical research in pediatric endocrinology 2025; doi:10.4274/jcrpe.galenos.2025.2025-6-7.
PMID: 40960072
7
Resistance to Thyroid Hormone Beta in a Patient Born to a Mother With Undiagnosed Graves' Disease.
Seetharaman S, Quintos JB, Salas-Lucia F
AACE clinical case reports 2023; (9(3)):63-66 doi:10.1016/j.aace.2023.02.003.
PMID: 37251972
8
TRIAC Therapy Relieves Hyperthyroid Symptoms, Lowering T4, T3, and Metabolic Rate in Resistance to Thyroid Hormone β.
Moran C, Martin-Grace J, Lyons G, et al.
The Journal of clinical endocrinology and metabolism 2026; (111(4)):980-987 doi:10.1210/clinem/dgaf583.
PMID: 41131705
9
Molecular mechanisms underlying the effectiveness of triiodothyroacetic acid (Triac) in patients with resistance to thyroid hormone β (RTHβ): a multicentre, international, retrospective cohort study.
Liao W, Marelli F, Moran C, et al.
EBioMedicine 2026; (133()):106512 doi:10.1016/j.ebiom.2026.106512.
PMID: 42874294
10
Triiodothyroacetic Acid Cross-Reacts With Measurement of Triiodothyronine (T3) on Various Immunoassay Platforms.
Chan SL, Refetoff S, Babic N, et al.
American journal of clinical pathology 2022; (157(2)):156-158 doi:10.1093/ajcp/aqab124.
PMID: 34542585
11
Clinical outcomes of 34 patients with resistance to thyroid hormone beta: a twenty-year experience in Japan.
Ohba K, Sasaki S, Misawa Nakamura H, et al.
Endocrine journal 2022; (69(2)):179-188 doi:10.1507/endocrj.EJ21-0390.
PMID: 34556608
12
Challenging diagnosis of resistance to thyroid hormone in a patient with COVID-19, pituitary microadenoma and unusual response to octreotide long-acting release test.
Petolicchio C, Brasili S, Gay S, et al.
Endocrinology, diabetes & metabolism case reports 2024; (2024(2)).
PMID: 38642577
13
Graves' disease coexisting with resistance to thyroid hormone: a rare case.
Sun H, Xu S, Xie S, et al.
Clinical case reports 2018; (6(2)):337-341 doi:10.1002/ccr3.1344.
PMID: 29445473
14
Pituitary resistance to thyroid hormone caused by a novel mutation (H435A) in the thyroid hormone receptor beta: A case report.
Yu C, Zhao J, Yao J, et al.
Medicine 2018; (97(21)):e10544 doi:10.1097/MD.0000000000010544.
PMID: 29794730
15
Resistance to Thyroid Hormone Alpha in an 18-Month-Old Girl: Clinical, Therapeutic, and Molecular Characteristics.
van Gucht AL, Meima ME, Zwaveling-Soonawala N, et al.
Thyroid : official journal of the American Thyroid Association 2016; (26(3)):338-46 doi:10.1089/thy.2015.0463.
PMID: 26782358
16
Long-term follow-up results and treatment outcomes of children and adults with resistance to thyroid hormone alpha.
Erbaş IM, Çakır MD, Yener AS, Demir K
Journal of endocrinological investigation 2023; (46(9)):1855-1863 doi:10.1007/s40618-023-02043-1.
PMID: 36821077
17
Thyroxine Treatment of Adult RTHα Patients: Safety, Efficacy, and Metabolomic Changes.
Westbye AB, Dahll LK, Bredahl MK, et al.
Thyroid : official journal of the American Thyroid Association 2026; (36(7)):788-794 doi:10.1177/10507256261460201.
PMID: 42273878
18
Resistance to Thyroid Hormone Alpha: Clinical Spectrum, Diagnostic Clues, and Therapeutic Strategies - A Narrative Review.
Amer B, Haidarah A, Alam A, Kamrul-Hasan ABM
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; doi:10.1016/j.eprac.2026.09.118.
PMID: 42843455
19
Early Diagnosis and Treatment of an Infant with a Novel Thyroid Hormone Receptor α Gene (pC380SfsX9) Mutation.
Furman AE, Dumitrescu AM, Refetoff S, Weiss RE
Thyroid : official journal of the American Thyroid Association 2021; (31(6)):1003-1005 doi:10.1089/thy.2020.0695.
PMID: 33198587

This page explains treatment and monitoring approaches for thyroid hormone resistance for educational purposes only and does not constitute medical advice. An endocrinologist should interpret your results and help decide whether observation, symptom treatment, or hormone therapy is appropriate.